Adaptimmune Therapeutics
(ADAP)
undefined
undefined%
At close: undefined
0.58
-0.38%
After-hours Dec 13, 2024, 07:03 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 143.99M | 108.03M | 149.95M | 56.88M | 50.41M | 68.38M | 84.04M | 158.78M | 229.06M | 51.27M | 247.79K | 3.02M |
| Short-Term Investments | 2.95M | 96.57M | 219.63M | 311.33M | 39.13M | 136.75M | 124.22M | 22.69M | 55.30M | - | - | - |
| Long-Term Investments | - | 1.57M | 1.72M | 4.60M | 4.50M | 4.10M | 4.25M | 4.02M | 4.48M | - | - | - |
| Other Long-Term Assets | 3.03M | 1.57M | 1.72M | 4.60M | 7.00M | 8.05M | 8.95M | 6.60M | 4.71M | - | - | - |
| Receivables | 46.92M | 7.43M | 752.00K | 139.00K | 19.28M | 192.00K | 206.00K | 1.48M | 5.45M | 4.00K | 27.37K | 680.11K |
| Inventory | - | 1.28M | 746.00K | 2.09M | 1.46M | 1.09M | 3.76M | 1.19M | 102.21K | 1.00 | 2.00 | 0.13 |
| Other Current Assets | 13.70M | 51.52M | 54.17M | 34.02M | 10.20M | 32.05M | 24.08M | 21.99M | 5.20M | 10.64M | 1.37M | 605.73K |
| Total Current Assets | 207.55M | 255.37M | 415.46M | 398.15M | 120.49M | 231.09M | 230.18M | 198.75M | 295.11M | 54.09M | 1.60M | 3.87M |
| Property-Plant & Equipment | 71.71M | 71.53M | 51.37M | 46.66M | 51.86M | 36.12M | 40.68M | 27.90M | 5.39M | 1.43M | 208.27K | 97.38K |
| Goodwill & Intangibles | 330.00K | 442.00K | 1.00M | 1.73M | 2.20M | 1.47M | 1.34M | 1.27M | 177.69K | - | - | - |
| Total Long-Term Assets | 75.06M | 73.55M | 54.09M | 52.99M | 61.05M | 45.64M | 50.96M | 35.76M | 5.57M | 1.43M | 208.27K | 97.38K |
| Total Assets | 282.62M | 328.92M | 469.55M | 451.14M | 181.54M | 276.74M | 281.15M | 234.51M | 300.68M | 55.52M | 1.81M | 3.96M |
| Account Payables | 8.13M | 4.75M | 8.11M | 6.39M | 6.36M | 4.08M | 8.38M | 11.35M | 1.98M | 1.98M | 1.02M | 1.87M |
| Deferred Revenue | 28.97M | 23.52M | 22.20M | 2.83M | 2.13M | - | 38.73M | 11.39M | 20.91M | - | 1.00 | -1.54M |
| Short-Term Debt | 10.77M | 5.46M | 4.64M | 5.55M | 4.99M | - | - | - | 1.00 | - | 41.59M | 1.54M |
| Other Current Liabilities | 23.52M | 30.77M | 27.59M | 24.31M | 20.87M | 20.35M | 21.46M | 15.51M | 3.59M | -4.62M | 50.51M | 655.24K |
| Total Current Liabilities | 72.79M | 64.50M | 62.54M | 39.07M | 34.34M | 24.44M | 74.31M | 40.27M | 26.76M | 53.11M | 3.97M | 4.09M |
| Long-Term Debt | 39.70M | 40.70M | 46.30M | 41.88M | 45.93M | - | - | - | - | - | - | - |
| Other Long-Term Liabilities | -18.45M | -19.05M | -22.48M | -20.29M | -22.37M | 5.41M | 3.85M | 3.14M | -12.18M | - | - | - |
| Total Long-Term Liabilities | 170.31M | 182.54M | 201.04M | 70.84M | 23.56M | 5.41M | 3.85M | 28.10M | 14.31M | 1.01M | 3.45M | 556.03K |
| Total Liabilities | 243.10M | 247.04M | 263.58M | 109.92M | 57.91M | 29.85M | 78.16M | 68.37M | 41.07M | 53.11M | 3.97M | 4.09M |
| Total Debt | 25.23M | 23.08M | 25.47M | 23.71M | 25.46M | 136.75M | 124.22M | - | - | - | 1.54M | 1.54M |
| Common Stock | 1.86M | 1.40M | 1.34M | 1.32M | 943.00K | 939.00K | 854.00K | 683.00K | 668.31K | 3.41K | 1.52K | 1.57K |
| Retained Earnings | -1.02B | -909.30M | -743.85M | -585.76M | -455.66M | -318.50M | -231.63M | -161.49M | -47.16M | -32.26M | -17.64M | -9.66M |
| Comprehensive Income | -3.75M | -875.00K | -11.14M | -10.05M | -7.26M | -9.76M | -21.64M | -14.25M | 126.69M | 187.35K | -47.13K | -7.85K |
| Shareholders Equity | 39.51M | 81.88M | 205.96M | 341.23M | 123.64M | 246.88M | 202.98M | 166.14M | 259.61M | 2.41M | -2.16M | -125.66K |
| Total Investments | 2.95M | 96.57M | 219.63M | 311.33M | 39.13M | 136.75M | 124.22M | 22.69M | 55.30M | - | - | - |